ICU Medical, Inc. reported $2.16B of revenue over the trailing twelve months, −9.0% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.16B (to Q2 2026). Free cash flow: $153M, trailing twelve months to Q2 2026. Operating margin: 3.3%, trailing twelve months to Q2 2026. EPS: $1.19, trailing twelve months to Q2 2026.

ICUIICU Medical, Inc.

Healthcare

$160.40+22% 1Y

$160.40

$114.1352 weeks$187.34

ICUI as reported

ICU Medical, Inc. reported $2.16B of revenue over the trailing twelve months, −9.0% on the year before. 11 reported series are charted on this page, each one as filed.

$2.16B

Revenue, trailing twelve months · to Q2 2026 · −9.0% against the twelve months before

Free cash flow: $153M
Free cash flow · +153% year on year · trailing twelve months to Q2 2026
Operating margin: 3.3%
Operating margin · trailing twelve months to Q2 2026
EPS: $1.19
EPS · −178% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ICUI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.16B	−9.0%	Q2 2026
Net income	$109M	n/a	Q3 2021 · 19 quarters behind
EPS	$1.19	−178%	Q2 2026
Gross margin	39%	n/a	Q2 2026
Operating margin	3.3%	n/a	Q2 2026
Net margin	8.4%	n/a	Q3 2021 · 19 quarters behind
ROE	6.4%	n/a	Q3 2021 · 19 quarters behind
ROA	5.5%	n/a	Q3 2021 · 19 quarters behind
ROIC	1.5%	n/a	Q2 2026
Free cash flow	$153M	+153%	Q2 2026
P/E	135	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.